| 1. |
Basoli
A et al. A Prospective, Double-Blind, Multicenter,
Randomized Trial Comparing Ertapenem 3 Vs
≥5 Days in Community-Acuired Intraabdominal
Infection. J Gastrointest Surg.2008;12:592-600.
|
|
 |
| 2. |
Boyle-Vavra
S, Daum RS. Community-acquired methicillin-resistant
Staphylococcus aureus: the role of Panton-Valentine
leukocidin. Lab Invest. 2007;87:3-9. |
|
|
| 3. |
Klevens
R M et al. Invasive Methicillin-Resistant
Staphylococcus aureus Infections in the United
States. JAMA. 2007;298:1763-1771. |
|
|
| 4. |
Kollef
MH. Limitations of vancomycin in the management
of resistant staphylococcal infections. Clin
Infect Dis. 2007;45:S191-S195. |
|
|
| 5. |
Koperna
T et al. Relaparotomy in Peritonitis: Prognosis
and Treatment of Patients with Persisting
Intraabdominal Infection. World J Surg.
2000;24:32-37. |
|
|
| 6. |
Mandell
LA et al. Infectious Diseases Society of America/American
Thoracic Society Consensus Guidelines on the
Management of Community-Acquired Pneumonia
in Adults. Clin Infect Dis. 2007;44(suppl
2):S27-S72. |
|
|
| 7. |
McDonald
LC. Trends in Antimicrobial Resistance in
Health Care–Associated Pathogens and
Effect on Treatment. Clin Infect Dis.
2006;42:S65-S71. |
|
|
| 8. |
Moore
MR et al. Population Snapshot of Emergent
Streptococcus pneumoniae Serotype 19A in the
United States, 2005. J Infect Dis.
2008;197:1016-1027. |
|
|
| 9. |
Mosdell
DM et al. Antibiotic treatment for surgical
peritonitis. Ann Surg. 1991;214:543-549. |
|
|
| 10. |
Wenisch
C et al. Moxifloxacin versus Standard Therapy
in Patients with Pneumonia Hospitalized after
Failure of Preclinical Anti-infective Treatment.
Infection. 2006;34:190-195. |
| |
|
Additional
Resources
Alexander
Project 1992–2001. Available at http://www.alexandernetwork.com. |
